Milk thistle shows potential in treatment
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.
We explored the potential of intravenous silibinin, a milk thistle extract, in treating an HIV-HCV coinfected patient who didn't respond to standard therapy. After just two weeks of silibinin treatment, both HCV and HIV levels became undetectable.
While silibinin appeared promising, leading to a trend of increased CD4+ cells, the follow-up showed that HIV levels returned to their previous state after stopping additional therapy.
These findings suggest that while silibinin may help some, more research is needed to understand its benefits fully.
Therapeutic benefits
Most Useful Review
32 people found this helpful
This product is incredibly safe and offers unmatched protection for the liver. Clinical studies indicate that standardized milk thistle, particularly in doses of around 600 mg, can improve conditions such as alcohol-related liver disease, hepatitis, and liver cirrhosis over 8-12 weeks. It’s essential to consult a physician before use, but this product is both beneficial and safe while taking prescriptions.